Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Biovica International AB | 141,000 | net | 15 Jul 2022 | tx 12+151,000−10,000 |
| W5 Solutions AB (publ) | 20,700 | net | 06 Aug 2025 | tx 2+20,700 |
| THQ Nordic AB | 3,500 | net | 30 May 2023 | tx 1+3,500 |
| Ovzon AB | 1,563 | net | 15 Aug 2025 | tx 4+2,563−1,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Aug 2025 | PURCHASE | Ovzon AB | 2,500 | 40.30 SEK | |
| 06 Aug 2025 | PURCHASE | W5 Solutions AB (publ) | 700 | 65.10 SEK | first after silence |
| 23 Jun 2025 | GRANT_AWARD | W5 Solutions AB (publ) | 20,000 | 9.47 SEK | deriv |
| 30 May 2023 | PURCHASE | THQ Nordic AB | 3,500 | 23.14 SEK | |
| 02 Sept 2022 | SALE | Ovzon AB | 1,000 | 45.00 SEK | |
| 15 Jul 2022 | OTHER | Biovica International AB | 20,000 | 0.00 SEK | deriv |
| 15 Jul 2022 | PURCHASE | Biovica International AB | 20,000 | 17.16 SEK | |
| 14 Dec 2021 | PURCHASE | Biovica International AB | 25,000 | 2.61 SEK | derivfirst after silence |
| 22 Jan 2021 | SALE | Biovica International AB | 10,000 | 25.24 SEK | deriv |
| 25 Jan 2021 | OTHER | Biovica International AB | 10,000 | 20.93 SEK | deriv |
| 25 Jan 2021 | OTHER | Biovica International AB | 10,000 | 20.93 SEK | |
| 28 Oct 2020 | PURCHASE | Biovica International AB | 20,000 | 3.31 SEK | deriv |
| 18 Jun 2020 | PURCHASE | Ovzon AB | 18 | 40.00 SEK | |
| 16 Jun 2020 | PURCHASE | Ovzon AB | 45 | 40.00 SEK | |
| 31 Oct 2019 | PURCHASE | Biovica International AB | 20,000 | 1.23 SEK | deriv |
| 10 May 2019 | PURCHASE | Biovica International AB | 1,000 | 10.00 SEK | |
| 14 Dec 2018 | PURCHASE | Biovica International AB | 20,000 | 0.44 SEK | deriv |
| 13 Dec 2018 | PURCHASE | Biovica International AB | 3,000 | 8.85 SEK | |
| 23 Mar 2018 | PURCHASE | Biovica International AB | 2,000 | 10.40 SEK |
2 purchases reported after at least 12 months of silence — most recent on 06 Aug 2025.